141 related articles for article (PubMed ID: 19948469)
1. Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.
Schulmeister L
Clin J Oncol Nurs; 2009 Dec; 13(6):711-4. PubMed ID: 19948469
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
4. Transdermal medication delivery helps prevent CINV.
Becze E
ONS Connect; 2010 Jan; 25(1):14-5. PubMed ID: 20157952
[No Abstract] [Full Text] [Related]
5. Effectiveness of oral 5-HT3 receptor antagonists for emetogenic chemotherapy.
Anastasia PJ
Oncol Nurs Forum; 2000 Apr; 27(3):483-93. PubMed ID: 10785902
[TBL] [Abstract][Full Text] [Related]
6. Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapy.
Keating GM; Duggan ST; Curran MP
CNS Drugs; 2012 Sep; 26(9):787-90. PubMed ID: 22834568
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
9. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M
Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254
[TBL] [Abstract][Full Text] [Related]
10. Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
Coluzzi F; Mattia C
Future Oncol; 2016 Aug; 12(16):1865-76. PubMed ID: 27184113
[TBL] [Abstract][Full Text] [Related]
11. Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
Yang LQ; Sun XC; Qin SK; Chen YX; Zhang HL; Cheng Y; Chen ZD; Shi JH; Wu Q; Bai YX; Han BH; Liu W; Ouyang XN; Liu JW; Zhang ZH; Li YQ; Xu JM; Yu SY
Chin Clin Oncol; 2016 Dec; 5(6):79. PubMed ID: 28061543
[TBL] [Abstract][Full Text] [Related]
12. [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
Mabro M; Cohn R; Zanesco L; Madon E; Hahlen K; Margueritte G; Breatnach F; Gentet JC; Plouvier é
Bull Cancer; 2000 Mar; 87(3):259-64. PubMed ID: 10779814
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of two oral dose regimens of granisetron.
Maisano R; Adamo V; Settineri N; Pergolizzi S; Scimone A; Altavilla G
Anticancer Res; 1995; 15(5B):2287-90. PubMed ID: 8572639
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.
Boccia RV; Gordan LN; Clark G; Howell JD; Grunberg SM;
Support Care Cancer; 2011 Oct; 19(10):1609-17. PubMed ID: 20835873
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
Bots MW; Dijkstra HJ; Blijham GH; van der Wall E; Fehmers MC; Keizer HJ; Nortier JW; Siegenbeek van Heukelom L; Slee PH; Veenhof CH
Neth J Med; 1992 Jun; 40(5-6):221-6. PubMed ID: 1331830
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
[TBL] [Abstract][Full Text] [Related]
18. Granisetron: is there a dose-response effect on nausea and vomiting?
Minami M
Cancer Chemother Pharmacol; 2003 Aug; 52(2):89-98. PubMed ID: 12783208
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
[TBL] [Abstract][Full Text] [Related]
20. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
Perez EA
Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
